Sense Biodetection
Brett has over 25 years of experience in leading strategic investing in venture capital, mergers & acquisitions, private equity and growth equity. As Managing Director at Koch Disruptive Technologies (KDT), Brett has led investment initiatives across software, medtech, life sciences, semiconductors, and industrial technology.
Brett is currently a board member at Vayyar Imaging, an Israel-based 4D imaging radar solutions company, and INSIGHTEC, a transformative healthcare platform applying focused ultrasound. Over his 20+ years at Koch Industries, Brett served as Managing Director at Koch Equity Development where he was involved in acquisitions, divestitures, and structured equity investments; Vice President at INVISTA, a subsidiary of Koch Industries, where he helped lead the company’s global expansion in its nylon intermediates business; and Managing Director at Koch Ventures where he helped develop and lead Koch’s initial venture investment strategy. Brett holds a bachelor’s degree from Weber State University and a MBA in Finance and Strategy from Brigham Young University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sense Biodetection
Sense Biodetection provides diagnostic technologies that deliver incredibly fast, accurate results, are easy for clinicians to master, and offer the flexibility to run one test or dozens at the same time.